Psoriasis (PsO) is a disease in which rough, scaly patches of skin develop on a significant portion of the body, most commonly the knees, elbows, trunk, and scalp. This condition has daily negative implications for quality of life that include constant itchiness, psychiatric comorbidities, and social impact, especially in children. 40% of patients with PsO further develop psoriatic arthritis (PsA), which causes joint pain and swelling that can lead to permanent deformities. Education about PsO and PsA is sorely lacking despite the fact that 85% of dermatologists consider it to be the highest unmet need in PsO/PsA treatment. This lack of education is keenly felt among nurse practitioners (NPs) and physician associates (PAs), who are often tasked as patient-facing clinicians to facilitate conversations about disease management, weigh treatment options, provide counseling, and monitor outcomes. It is crucial that clinicians collaborating with a multidisciplinary care team in the dermatology and rheumatology field be knowledgeable on key patient concerns arising from PsO and PsA to best account for patient needs.
In the first activity of this CME Outfitters BriefCase series, expert faculty utilize case-based learning to guide learners through evaluating the impact of PsO and PsA on individual needs and concerns.
At the conclusion of this activity, learners will be able to better:
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.- both are Johnson & Johnson companies.
Physicians, nurse practitioners (NPs), and physician associates (PAs) specializing in dermatology and rheumatology
In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education Credit for learning and change.
CME Outfitters, LLC, designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is designated for 0.50 contact hours.
California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until 02/28/25. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Ms. Faleye reports the following financial relationships:
Advisory Board: AbbVie Inc.; Bristol Myers Squibb Company; Lilly; Novartis; Pharmaceuticals Corporation; Pharmaceuticals Inc./Sanofi; Sun Pharma; and UCB, Inc.
Speakers Bureau: AbbVie Inc.; Bristol Myers Squibb Company; Lilly; Pharmaceuticals Corporation; Pharmaceuticals Inc./Sanofi; Sun Pharma; and UCB, Inc.
The following individuals have no financial relationships to disclose:
Amanda K. Smith, PA-C (Peer Reviewer)
Keshia Pitt, PhD (Planning Committee)
John Jones, PharmD (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac.
Call us at 877.CME.PROS (877.263.7767).
BC-116-022824-01
